CBM Quote, Trading Chart, Cambrex Corporation

$ Last:

0.00% Change Percent:

$59.59 Open:

$59.53 Previous Close:

$59.62 High:

$59.52 Low:

285,608 Volume:

01/01/1970 12:00:00 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2019-10-17	59.59	59.53	59.62	59.52	285,608
2019-10-16	59.68	59.53	59.73	59.53	852,596
2019-10-15	59.72	59.70	59.73	59.68	355,183
2019-10-14	59.66	59.72	59.7459	59.65	272,984
2019-10-11	59.62	59.66	59.73	59.62	386,092
2019-10-10	59.58	59.58	59.63	59.55	381,874
2019-10-09	59.58	59.59	59.60	59.52	260,205
2019-10-08	59.57	59.53	59.62	59.51	503,618
2019-10-07	59.60	59.59	59.635	59.55	359,248
2019-10-04	59.58	59.63	59.72	59.55	226,942
2019-10-03	59.46	59.58	59.62	59.43	339,089
2019-10-02	59.55	59.46	59.60	59.38	532,825
2019-10-01	59.60	59.54	59.62	59.51	868,382
2019-09-30	59.65	59.50	59.67	59.49	639,183
2019-09-27	59.69	59.65	59.69	59.59	851,274
2019-09-26	59.67	59.61	59.75	59.58	194,356
2019-09-25	59.61	59.63	59.69	59.61	205,475
2019-09-24	59.63	59.60	59.69	59.59	353,508
2019-09-23	59.60	59.60	59.65	59.55	1,108,254
2019-09-20	59.65	59.66	59.82	59.63	329,591

Stock Information

Cambrex Corporation Company Name:

CBM Stock Symbol:

NYSE Market:

Cambrex Corporation Website:

Get CBM Alerts

News, Short Squeeze, Breakout and More Instantly...

CBM - Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility

EAST RUTHERFORD, N.J., April 07, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced it has completed an expansion of its biopharmaceutical analysis capabilities...
CBM - Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit

EAST RUTHERFORD, N.J., March 31, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that Troy Player has been appointed as President, Early Stage Development an...
CBM - Cambrex Announces Management Changes and Board Appointments

EAST RUTHERFORD, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced changes to its management team and Board of Directors to accelera...